Anthocyanins are polyphenolic ring-based flavonoids, and are widespread in fruits and vegetables of red-blue color. Epidemiological investigations and animal experiments have indicated that anthocyanins may contribute to cancer chemoprevention. The studies on the mechanism have been done recently at molecular level. This review summarizes current molecular bases for anthocyanidins on several key steps involved in cancer chemoprevention: (i) inhibition of anthocyanidins in cell transformation through targeting mitogen-activated protein kinase (MAPK) pathway and activator protein 1 (AP-1) factor; (ii) suppression of anthocyanidins in inflammation and carcinogenesis through targeting nuclear factor kappa B (NF-κB) pathway and cyclooxygenase 2 (COX-2) gene; (iii) apoptotic induction of cancer cells by anthocyanidins through reactive oxygen species (ROS) / c-Jun NH 2 -terminal kinase (JNK)-mediated caspase activation. These data provide a first molecular view of anthocyanidins contributing to cancer chemoprevention.
INTRODUCTION
Anthocyanins are naturally occurring polyphenolic compounds that give the intense color to many fruits and vegetables such as berries, red grapes, purple sweet potato, and red cabbages [1, 2] . In contrast to the other flavonoids, anthocyanins carry a positive charge in the central ring structure and are thus cations. In plants, they are present exclusively as glycosidic compounds. The number and nature of the different attached sugar moieties are responsible for the high number of anthocyanins, more than 500 compounds [3] . The aglycone (named anthocyanidin) is a diphenylpropane-based polyphenolic ring structure, and is limited to a few structure variants including delphinidin, cyanidin, petunidin, pelargonidin, peonidin, and malvidin (Figure 1) , that represent the aglycones of most anthocyanins in plants.
Based on food composition data, we consume considerable amounts of anthocyanins from crops, fruits, and vegetable-based diets [4] although the range is from several milligrams to several hundred milligrams, depending on the nutrition customs. An enhanced intake of anthocyanin is now increasing because extracts with higher anthocyanin contents from bilberry or elderberry are commercially available. Epidemiological investigations have indicated that moderate consumption of anthocyanins through the intake of products such as red wine [5] or bilberry extract [6] is associated with a lower risk of coronary heart disease. Recent studies indicated that anthocyanins have strong free radical scavenging and antioxidant activities [7, 8, 9, 10, 11, 12, 13] , and show inhibitory effects on the growth of some cancer cells [14, 15, 16, 17, 18] . Animal experiments showed that oral intake of anthocyanins from purple sweet potato (Ipomoea batatas L.) and red cabbage (Brassica oleracea L.) suppressed rat colon carcinogenesis induced by 1, 2-dimethylhydrazine and 2-amino-1-methyl-6-phenylimidazo- [4,5-b] pyridine [19] . In addition, anthocyanins can be directly absorbed and distributed to the blood in human and rats after consumption of dietary anthocyanins [18, 19, 20, 21, 22, 23, 24] . These facts suggest that anthocyanins may play a role in cancer chemoprevention. Thus, mechanisms behind chemopreventive effects of anthocyanins need to be considered at molecular level.
ANTICARCINOGENESIS THROUGH TARGETING MAPK PATHWAY AND AP-1 FACTOR
AP-1 is a transcription factor and has been shown to play a critical role in promoting carcinogenesis [25, 26] . In mouse epidermal cell line JB6 ( + ), tumor promoters such as 12-O-tetradecanoylphorbol-13-acetate (TPA), epidermal growth factor (EGF), and tumor necrosis factor (TNF) alpha can induce AP-1 activity and neoplastic transformation by activating MAPK including extracellular signal-regulated kinase (ERK), JNK, or p38 kinase [ 27, 28] . Delphinidin, cyanidin, and petunidin have been shown to inhibit TPA-induced AP-1 transcriptional activity and cell transformation in JB6 cells [29] . Structureactivity studies indicated that the ortho-dihydroxyphenyl structure on the B-ring of anthocyanidins seems essential for the inhibitory action because pelargonidin, peonidin, and malvidin, having no such ortho-dihydroxyphenyl structure, failed to show the inhibitory effects in both AP-1 activity and cell transformation. The results from signal transduction analysis indicated that delphinidin blocked ERK phosphorylation at early times and JNK phosphorylation at later times, but not p38 phosphorylation at any time [29] . Moreover, delphinidin blocked the phosphorylation of MAPK/ERK kinase (MEK, an ERK kinase), SAPK/ERK kinase (SEK, a JNK kinase), and c-Jun (a phosphorylation target of ERK and JNK). The data suggest that the inhibition of TPA-induced AP-1 activity and cell transformation by delphinidin involves the blockage of ERK and JNK signaling cascades (Figure 2 ). Furthermore, a greater inhibition was observed in combinations of superoxide dismutase (SOD) with anthocyanidins that have the ortho-dihydroxyphenyl structure on the B-ring. Multiplicative model analysis suggested that this greater inhibition between SOD and delphinidin is synergistic, not additive [29] . Thus, the inhibitory effects of anthocyanidins on AP-1 activation and cell transformation would be due in part to their potent scavenging activity for superoxide radicals and in part to MAPK blockage. SOD has been shown to selectively inhibit the TPAinduced activation of protein kinase Epsilon and to prevent subsequent activation of JNK2 in response to TPA, thereby delaying AP-1 activation and inhibiting mouse skin tumor promotion [30] . Thus, the signaling pathways blocked by delphinidin or SOD may differ in part although both are considered to be important in the cancer prevention activity of anthocyanidins.
ANTI-INFLAMMATION THROUGH TARGETING NF-κB PATHWAY AND COX-2 GENE
Cyclooxygenase (COX) is the rate-limiting enzyme for synthesis of dienoic eicosanoids such as prostaglandin (PG) E2. COX exists in three isoforms [31, 32] . COX-1 is expressed constitutively in many types of cells and is responsible for the production of PGs under physiological conditions. COX-3 is a COX-1 variant and is mainly expressed in cerebral cortex. Analgesic/antipyretic drugs such as acetaminophen, phenacetin, antipyrine, and dipyrone can selectively inhibit this enzyme. Thus, inhibition of COX-3 could represent a primary central mechanism by which these drugs decrease pain and possibly fever [31] . COX-2 is induced by proinflammatory stimuli, including mitogens, cytokines, and bacterial lipopolysaccharide (LPS) in cells in vitro and in inflamed sites in vivo [33] . Data indicate that COX-2 is involved in many inflammatory processes and induced in various carcinomas, suggesting that COX-2 plays a key role in tumorigenesis [34] . Interestingly, some antioxidants with chemopreventive effects inhibit the expression of COX-2 by interfering with the signaling mechanisms that regulate the COX-2 gene [35] . Wang et al [36] found that anthocyanins and their aglycone, cyanidin, from tart cherries could inhibit the activities of COX-1 and COX-2. Seeram et al [37] found that cyanidin showed superior inhibition of the cyclooxygenase activity in vitro. In our laboratory, we used mouse macrophage cell line RAW264 to demonstrate the molecular mechanism of anthocyanins in the inhibition of the COX-2 gene. We found that anthocyanin extracts from bilberry or purified delphinidin inhibited LPS-induced COX-2 expression at protein and transcriptional levels. Studies on signal pathway indicated that delphinidin at least blocked LPS-induced IκB degradation and then suppressed NF-κB activation and COX-2 gene expression (Hou et al, unpublished data) . These data demonstrated that the blockage of NF-κB signaling pathway is involved in the inhibition of COX-2 gene expression by anthocyanins (Figure 2 ).
ANTITUMOR PROGRESSION THROUGH OXIDATIVE/JNK-MEDIATED APOPTOSIS
Apoptosis has been reported to play an important role in elimination of seriously damaged cells or tumor cells by chemopreventive agents [38, 39] . The cells that have undergone apoptosis have typically shown chromatin condensation and DNA fragmentation [40] . They are rapidly recognized by macrophages before cell lysis, and then can be removed without inducing inflammation [38, 41] . Therefore, apoptosis-inducing agents are expected to be ideal anticancer drugs of which human promyelocytic leukemia cell line (HL-60) provides a valid model for testing antileukemic or general antitumoral compounds [42] . Delphinidin, cyanidin, and petunidin induced apoptosis of HL-60 cells detected by morphological changes and by DNA fragmentation, whereas pelargonidin, peonidin, and malvidin showed no induction of apoptosis [43] . The anthocyanidin glycosides (anthocyanins) extracted from bilberry such as delphinidin glycosides and cyanidin glycosides also induced the apoptosis in HL-60 cells [44] . Structure-activity studies indicated that the potency of apoptosis induction of anthocyanidins is associated with the number of hydroxyl groups at the B-ring, and the ortho-dihydroxyphenyl structure at the B-ring appears essential for apoptosis actions [43] . It is noteworthy that anthocyanidins increased the levels of hydrogen peroxide in HL-60 cells with a structure-activity relationship that depends on the number of hydroxyl groups at the B-ring [43] and appears in the order of delphinidin > cyanidin, petunidin > pelargonidin, peonidin, and malvidin.
The mechanistic analysis indicates that the apoptosis induction by delphinidin may involve an oxidation/JNKmediated caspase pathway. Delphinidin treatment increased the levels of intracellular ROS, which may be a sensor to activate JNK. Concomitant with the apoptosis, JNK pathway activation such as JNK phosphorylation, c-jun gene expression, and caspase-3 activation was observed in delphinidin-treated cells [43] . Antioxidants such as N-acetyl-L-cysteine (NAC) and catalase effectively blocked delphinidin-induced JNK phosphorylation, caspase 3 activation, and DNA fragmentation [43] . Thus, delphinidin may trigger an apoptotic death program in HL-60 cells through an oxidative stress-mediated JNK signaling cascades (Figure 2 ). It is interesting that anthocyanidins produced ROS, showing pro-oxidant activities, to induce apoptosis in HL-60 cells, contrary to the antioxidant activities of anthocyanidins in the inhibition of TPA-induced cell transformation in mouse skin JB6 cells [29] .
It should be noted that anthocyanidins are the aglycons of the naturally occurring anthocyanins. Most of the molecular results on biological activities of anthocyanins were from anthocyanidins due to the fact that anthocyanidins are easier to be prepared than anthocyanins. Thus, it is not yet known whether the naturally occurring anthocyanins will also activate these molecular pathways. Accumulated results on structure-activity studies have shown that the biological activities of anthocyanins appear to increase with a decreasing number of sugar units and/or with an increasing number of hydroxyl groups at their aglycons [7] . For example, both antioxidant activity and cyclooxygenase inhibitory activity of cyanidin glycosides increased with a decreasing number of sugar units. Cyanidin-rutinose showed better activity than cyanidin-glucosylrutinose, and cyanidin aglycone showed the best activity at much lower concentrations [37] . In our laboratory, we found that the aglycons with ortho-dihydroxyphenyl structure at the B-ring, such as delphinidin and cyanidin [29, 43] and their glycosides (Hou et al, unpublished data) , possessed the activities of anticarcinogenesis, anti-inflammation, and apoptosis induction. The ortho-dihydroxyphenyl structure on the Bring appears essential for these actions, and the activities of aglycons such as delphinidin and cyanidin are stronger than that of their glycosides.
CONCLUSION
The molecular mechanisms of anticarcinogenesis, anti-inflammation, and apoptosis induction of malignant cells by anthocyanidins have been demonstrated at molecular level. These data provide a first molecular view of the chemopreventive effects of anthocyanidins. Based on many genes that may be associated with cancer chemoprevention, a genome-wide gene analysis by using microarray technology will be required to get the whole view of molecular mechanisms of cancer chemoprevention by anthocyanidins.
